Safi Silver Corp (TM) Fair Value & Analysis
Healthcare · CA · Market cap 280M THB
Fair value as of: Jun 25, 2026
From 23 valuation models · updated 4 days ago
Fair value updated Jun 25, 2026 — revised from 1.88 THB to 1.54 THB (−18.1%) since Jun 24, 2026. Share price +3.3% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.7100 THB – 1.11 THB · fair‑value band 1.14 THB – 2.15 THB · the 0.9300 THB price screens below the 1.54 THB fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Safi Silver Corp (TM) currently trades at 0.9300 THB, while our model-based Fair Value estimate is 1.54 THB — implying the stock looks roughly 65.6% undervalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Safi Silver Corp generated revenue of 717M THB at a net margin of 4.0%. Revenue grew 6.6% year over year. It earns a return on equity of 5.3%. Net debt stands at 289M THB. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
Safi Silver Corp., together with its subsidiaries, engages in the acquisition, exploration, development, and maintenance of silver projects in southern Morocco. The company operates the Addana project, targeting structurally controlled vein systems across the 112 km² permit package; the Silver Hill Project, an early-stage copper-silver exploration project; and the Kalahari Copper Project. The company was formerly known as Trigon Metals Inc. and changed its name to Safi Silver Corp. in April 2026. The company is headquartered in Toronto, Canada.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Safi Silver Corp reported revenue of 705M THB in FY2025 versus 674M THB in FY2021, a compound +1.1%/yr. Reported net income was 27.5M THB in FY2025, compounding −2.5%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation M1CK34 | R$999.49 | R$1,236 | +24% |
| Cencora, Inc C1CO34 | R$709.32 | R$400.70 | -44% |
| Cardinal Health, Inc CAH | $201.74 | $92.07 | -54% |
| Sigma Healthcare Limited SIGGF | $2.35 | $0.6300 | -73% |
| Sitka Gold Corp SIG | A$2.74 | A$0.3300 | -88% |
| Shanghai Pharmaceuticals Holding 601607 | ¥15.96 | ¥45.15 | +183% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Safi Silver Corp (TM) undervalued?
What is the fair value of TM?
What is the quality score of TM?
What is the revenue of Safi Silver Corp (TM)?
What is the net profit margin of TM?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.